Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-27 @ 2:15 AM
Study NCT ID:
NCT04696393
Status:
COMPLETED
Last Update Posted:
2021-04-13
First Post:
2021-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Pharmacokinetics and Safety of Mitapivat 100 mg Tablet Formulation With Mitapivat 2 × 50 mg Tablet Formulation in Healthy Adult Participants
Sponsor:
Agios Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-04
First Submit QC Date:
None
Study First Post Date:
2021-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-12
Last Update Post Date:
2021-04-13
Last Update Post Date Type:
ACTUAL